Holly B. Kordasiewicz serves as EVP, Chief Development Officer at IONIS PHARMACEUTICALS INC, where they oversee executive responsibilities. Since joining the company, Holly B. Kordasiewicz has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jan 2, 2026 involved receiving (via award) 9,100 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Jan 2, 2026 | IONS | $0 | Award | 9,100 | $N/A | Discretionary |
Holly B. Kordasiewicz currently holds 9,100 shares of IONIS PHARMACEUTICALS INC (IONS), valued at approximately $0. This represents their equity stake as EVP, Chief Development Officer.
Based on SEC Form 4 filings, Holly B. Kordasiewicz has been a net neutral trader of IONS stock. They have purchased $0 and sold $0 worth of shares.
Holly B. Kordasiewicz's most recent insider trade was on Jan 2, 2026, when they sold 9,100 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted